ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

CCOP 2 Under Way After Bitter Recompetition Cancer Control Protocols Being Review; PLs, Affiliates Listed

February 19, 1988

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

October 19, 1990

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

NCAB Working Group Renamed, Adds Karen Antman

December 16, 1994